Novartis commits $23 billion to expand U.S. manufacturing and R&D with 10 new facilities, aiming to produce all key U.S.

KalVista's sebetralstat nears FDA approval as a first-in-class oral treatment for hereditary angioedema. Read here for an ...

United Therapeutics is building the Silver Spring public parking facility under a development agreement with Montgomery ...

Amid a massive reorganization of the federal healthcare infrastructure that has prompted pushback from biotech and healthcare ...

All three of the major indexes (^DJI, ^GSPC, ^IXIC) closed higher in what was a wild week of trading. Market Domination Overtime Anchor Julie Hyman and Markets and Data Editor Jared Blikre break down ...

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

A new consortium aims to speed the pace of basic science discovery in AD and related diseases. A future AI assistant is to ...

In "Universality," language is weaponized, while "A Trial in Three Acts" brings legal proceedings and a theater play together ...

In his quiet moments at night, China’s President Xi Jinping probably can’t believe his luck as President Donald Trump lights ...

For any institution, having a strong leader is inevitably one of the most crucial factors in ensuring its success and defining its future. At a university like UW, the president has responsibilities ...

Verve Therapeutics (NASDAQ:VERV) stock gains as the company wins the FDA fast track designation for VERVE-102, a cholesterol ...

The CEOs of two major U.S. banks discussed President Donald Trump's tariffs in letters within their quarterly earnings ...